{
  "context": {
    "rules": [
      "Rule1: If the research facility receives government grant funding, then the research achieves a breakthrough",
      "Rule2: If the organization submits a clinical trial application, then the organization completes pre-clinical testing",
      "Rule3: If the organization completes pre-clinical testing, then the clinical trial receives regulatory body approval",
      "Rule4: If the organization develops an alternative compound, then researchers identify side effects",
      "Rule5: If researchers identify side effects, then researchers observe adverse reactions",
      "Rule6: If researchers identify side effects, then researchers do not modify the drug formulation",
      "Rule7: If researchers observe adverse reactions, then researchers modify the drug formulation",
      "Rule8: The platform achieves commercial success or the research achieves a breakthrough",
      "Rule9: If the platform faces market competition, then the platform does not achieve commercial success",
      "Rule10: If the research facility receives corporate grant funding, then the research achieves a breakthrough",
      "Rule11: If the company invests in a marketing campaign, then the platform faces market competition",
      "Rule12: The company implements a price reduction or the company launches a promotional offer",
      "Rule13: If the company launches a promotional offer, then under the condition that the company does not invest in a marketing campaign, the platform gains market share",
      "Rule14: If the company analyzes market data, then should the company implement a price reduction, given that the company does not invest in a marketing campaign, the platform gains market share",
      "Rule15: The company analyzes market data or the company conducts a consumer survey",
      "Rule16: If the company conducts a consumer survey, then whenever the company implements a price reduction and the company does not invest in a marketing campaign, the platform gains market share",
      "Rule17: If the material contains alcohol, then the material requires special storage",
      "Rule18: The material contains alcohol or the research achieves a breakthrough",
      "Rule19: The material degrades at room temperature or the material does not require special storage",
      "Rule20: If the research facility conducts research on plant extracts, then the research facility receives government grant funding",
      "Rule21: If the research facility conducts research on synthetic compounds, then the research facility receives corporate grant funding",
      "Rule22: If the research facility synthesizes plant extracts into drug compounds, then research on plant extracts does not progress",
      "Rule23: The research facility synthesizes plant extracts into drug compounds or the research facility conducts research on plant extracts or the research facility conducts research on synthetic compounds",
      "Rule24: If the organization publishes a research paper, then the research achieves a breakthrough",
      "Rule25: The organization publishes a research paper or the organization presents conference findings",
      "Rule26: If neither the platform receives regulatory approval nor the research achieves a breakthrough, then the organization develops an alternative compound",
      "Rule27: If it is not the case that filing a patent extension by the organization leads to extended patent protection, then the patent is challenged by generic manufacturers",
      "Rule28: If it is not the case that filing a patent extension by the organization leads to extended patent protection, then the patent is not challenged by generic manufacturers",
      "Rule29: If synthesizing plant extracts into drug compounds by the research facility does not result in progress of research on plant extracts, then a manufacturing process for plant extracts is designed",
      "Rule30: If synthesizing plant extracts into drug compounds by the research facility does not result in progress of research on plant extracts, then a manufacturing process for plant extracts is not designed",
      "Rule31: If presenting conference findings by the organization does not lead to research breakthrough, then the organization submits a clinical trial application",
      "Rule32: If the failure of presenting conference findings to lead to research breakthrough does not result in clinical trial approval by the regulatory body, then the organization files a patent extension",
      "Rule33: If the failure of presenting conference findings to lead to research breakthrough does not result in clinical trial approval by the regulatory body, then the organization does not extend patent protection"
    ],
    "facts": [
      "Fact1: The clinical trial does not receive regulatory body approval",
      "Fact2: The platform does not receive regulatory approval",
      "Fact3: The platform does not gain market share",
      "Fact4: The material does not degrade at room temperature"
    ]
  },
  "question": "The research achieves a breakthrough"
}